Specific passive immunity reduces the excretion of glycoprotein E-negative bovine herpesvirus type 1 vaccine strain in calves

By Lemaire M.   Hanon E.   Schynts F.   Meyer G.   Thiry E.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1013-1017

Elsevier

Access to resources Recommend Favorite

An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation

By Kaashoek M.J.   Moerman A.   Madic J.   Weerdmeester K.   Maris-Veldhuis M.   Rijsewijk F.A.M.   van Oirschot J.T.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 342-346

Elsevier

Access to resources Recommend Favorite

A quantitative study of the efficacy of a deletion mutant bovine herpesvirus-1 differential vaccine in reducing the establishment of latency by wildtype virus

By Galeota J.A.   Flores E.F.   Kit S.   Kit M.   Osorio F.A.  

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 123-128

Elsevier

Access to resources Recommend Favorite

The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1

By Papp Z.   Babiuk L.A.   Baca-Estrada M.E.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 933-943

Elsevier

Access to resources Recommend Favorite

Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine

By Bosch J.C.   Kaashoek M.J.   van Oirschot J.T.  

Vaccine, Vol. 15, Iss. 14, 1997-10 ,pp. : 1512-1517

Elsevier

Access to resources Recommend Favorite